$BBAI
BigBear.ai Holdings Inc Stock $bbai

$bbai Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024036497 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$41.51M	$39.78M
YoY Change	22.12%	3.44%
Cost Of Revenue	$30.74M	$28.72M
YoY Change	20.17%	-2.63%
Gross Profit	$10.77M	$11.06M
YoY Change	28.03%	23.43%
Gross Profit Margin	25.94%	27.81%
Selling, General & Admin	$17.49M	$23.36M
YoY Change	12.57%	38.0%
% of Gross Profit	162.41%	211.19%
Research & Development		$3.565M
YoY Change		60.22%
% of Gross Profit		32.22%
Depreciation & Amortization		$2.907M
YoY Change		46.89%
% of Gross Profit		26.28%
Operating Expenses	$17.49M	$26.93M
YoY Change	15.15%	40.58%
Operating Profit	-$10.54M	-$16.67M
YoY Change	28.34%	63.16%
Interest Expense		$4.331M
YoY Change		-164.83%
% of Operating Profit
Other Income/Expense, Net		$617.0K
YoY Change
Pretax Income	-$12.16M	-$11.72M
YoY Change	-404.33%	-30.63%
Income Tax	$21.00K	$15.00K
% Of Pretax Income
Net Earnings	-$12.18M	-$11.74M
YoY Change	-404.48%	-30.53%
Net Earnings / Revenue	-29.34%	-29.5%
Basic Earnings Per Share	-$0.05	-$0.05
Diluted Earnings Per Share	-$0.05	-$0.05
COMMON SHARES
Basic Shares Outstanding	250.1M shares	246.1M shares
Diluted Shares Outstanding	250.0M shares	246.3M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$72.27M
YoY Change		141.51%
Cash & Equivalents	$65.58M	$72.27M
Short-Term Investments
Other Short-Term Assets		$4.519M
YoY Change		-10.37%
Inventory
Prepaid Expenses
Receivables	$32.46M	$33.94M
Other Receivables		$0.00
Total Short-Term Assets	$104.2M	$111.8M
YoY Change	58.41%	56.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.519M	$1.586M
YoY Change	38.72%	32.28%
Goodwill	$118.6M	$118.6M
YoY Change	143.66%	143.66%
Intangibles	$119.3M	$118.2M
YoY Change	43.99%	44.23%
Long-Term Investments
YoY Change
Other Assets	$1.072M	$1.089M
YoY Change	137.17%	132.2%
Total Long-Term Assets	$249.9M	$249.1M
YoY Change	82.09%	82.31%
TOTAL ASSETS
Total Short-Term Assets	$104.2M	$111.8M
Total Long-Term Assets	$249.9M	$249.1M
Total Assets	$354.1M	$360.9M
YoY Change	74.42%	73.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.249M	$7.128M
YoY Change	-53.18%	-2.33%
Accrued Expenses	$26.36M	$20.38M
YoY Change	70.48%	30.36%
Deferred Revenue	$2.082M	$3.496M
YoY Change	-10.26%	74.8%
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due	$0.00	$417.0K
YoY Change		-20.11%
Total Short-Term Liabilities	$50.59M	$53.32M
YoY Change	-11.25%	-25.73%
LONG-TERM LIABILITIES
Long-Term Debt	$195.7M	$195.3M
YoY Change	1.01%	1.01%
Other Long-Term Liabilities		$9.562M
YoY Change
Total Long-Term Liabilities	$195.7M	$195.3M
YoY Change	1.01%	1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.59M	$53.32M
Total Long-Term Liabilities	$195.7M	$195.3M
Total Liabilities	$255.7M	$258.1M
YoY Change	0.14%	-4.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$462.5M	-$450.3M
YoY Change	58.29%	52.04%
Common Stock	$618.3M	$610.4M
YoY Change	108.01%	109.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$98.43M	$102.8M
YoY Change
Total Liabilities & Shareholders Equity	$354.1M	$360.9M
YoY Change	74.42%	73.32%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$12.18M	-$11.74M
YoY Change	-404.48%	-30.53%
Depreciation, Depletion And Amortization		$2.907M
YoY Change		46.89%
Cash From Operating Activities		-$7.058M
YoY Change		-44.84%
INVESTING ACTIVITIES
Capital Expenditures		$1.711M
YoY Change		85450.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		-$1.711M
YoY Change		85450.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-377.0K
YoY Change		-101.8%
NET CHANGE
Cash From Operating Activities		-7.058M
Cash From Investing Activities		-1.711M
Cash From Financing Activities		-377.0K
Net Change In Cash		-9.146M
YoY Change		-212.97%
FREE CASH FLOW
Cash From Operating Activities		-$7.058M
Capital Expenditures		$1.711M
Free Cash Flow		-$8.769M
YoY Change		-31.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1557000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	53000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	607000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	102756000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-54039000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3994000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	246303139	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145469043	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246303139	shares
CY2024Q2	us-gaap	Gross Profit GrossProfit	11063000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	8963000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	102756000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-67335000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	360883000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	199910000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39783000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38459000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	28720000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	29496000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23364000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16930000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3565000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2225000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4709000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3353000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	457000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	25000	usd
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	347000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16670000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10217000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3551000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3560000	usd
CY2024Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	7882000	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3121000	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	617000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11722000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16898000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-11737000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16895000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145469043	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	108482000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-11737000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5749000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-378000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16895000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1398000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-61573000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-67335000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-136884000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10906000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	119000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	207776000	usd
	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	90707000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-3140000	usd
	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	90707000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	607000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	102756000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-37872000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43109000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7799000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2237000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-61573000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-136884000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43109000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5346000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3965000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1012000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1006000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10906000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7799000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	bbai	Operating Lease Noncash Lease Expense OperatingLeaseNoncashLeaseExpense	363000	usd
	bbai	Operating Lease Noncash Lease Expense OperatingLeaseNoncashLeaseExpense	297000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	176000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	16110000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	13688000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6232000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7735000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-3781000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-966000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1243000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5244000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5047000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8124000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1652000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	660000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1469000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-22000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-275000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1066000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21417000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24813000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-13935000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3225000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10543000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	bbai	Proceeds From Issuance Of Shares For Exercised Rdo And Pipe Warrants ProceedsFromIssuanceOfSharesForExercisedRDOAndPIPEWarrants	53809000	usd
	bbai	Proceeds From Issuance Of Shares For Exercised Rdo And Pipe Warrants ProceedsFromIssuanceOfSharesForExercisedRDOAndPIPEWarrants	0	usd
	bbai	Proceeds From Issuance Of Private Placement And Registered Direct Offering Shares ProceedsFromIssuanceOfPrivatePlacementAndRegisteredDirectOfferingShares	0	usd
	bbai	Proceeds From Issuance Of Private Placement And Registered Direct Offering Shares ProceedsFromIssuanceOfPrivatePlacementAndRegisteredDirectOfferingShares	50000000	usd
	bbai	Payments For Repurchase Of Private Placement And Registered Direct Offering Transaction Costs PaymentsForRepurchaseOfPrivatePlacementAndRegisteredDirectOfferingTransactionCosts	0	usd
	bbai	Payments For Repurchase Of Private Placement And Registered Direct Offering Transaction Costs PaymentsForRepurchaseOfPrivatePlacementAndRegisteredDirectOfferingTransactionCosts	5225000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	812000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1537000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	607000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	119000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3140000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1132000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50583000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42106000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39709000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17291000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32557000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12632000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72266000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29923000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	207770000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000.0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	48683000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	118621000	usd
CY2024Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	138500000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000.0	usd
CY2024Q2	bbai	Goodwill Impairment Test Discount Rate GoodwillImpairmentTestDiscountRate	0.307
	bbai	Goodwill Impairment Test Excess Fair Value Over Carrying Value GoodwillImpairmentTestExcessFairValueOverCarryingValue	0	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	145918000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27721000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	118197000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	104628000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22588000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82040000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	200000	usd
CY2024Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	200000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2794000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1868000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5133000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3737000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6396000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13484000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13484000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12022000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7745000	usd
CY2024Q2	bbai	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	65066000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	118197000	usd
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	661000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1419000	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2056000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1246000	usd
CY2024Q2	us-gaap	Prepaid Taxes PrepaidTaxes	1754000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1784000	usd
CY2024Q2	bbai	Pre Contract Costs PreContractCosts	48000	usd
CY2023Q4	bbai	Pre Contract Costs PreContractCosts	0	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4519000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4449000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14251000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10118000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	589000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	560000	usd
CY2024Q2	bbai	Legal Accruals Current LegalAccrualsCurrent	2770000	usd
CY2023Q4	bbai	Legal Accruals Current LegalAccrualsCurrent	1253000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2765000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4302000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20375000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16233000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	200417000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	201229000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4750000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5727000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	195667000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	195502000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	417000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1229000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	195250000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	194273000	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	200000000.0	usd
CY2022Q4	bbai	Line Of Credit Facility Covenant Ability To Borrow Minimum Required Adjusted Ebitda For Two Preceding Quarters LineOfCreditFacilityCovenantAbilityToBorrowMinimumRequiredAdjustedEBITDAForTwoPrecedingQuarters	1	usd
CY2024Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M2D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y25D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1343
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1055
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	585000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	291000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	972000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	583000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	43000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	49000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	69000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	71000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	94000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	638000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	371000	usd
	us-gaap	Lease Cost LeaseCost	1055000	usd
	us-gaap	Lease Cost LeaseCost	748000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	19000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	52000	usd
	us-gaap	Sublease Income SubleaseIncome	42000	usd
	us-gaap	Sublease Income SubleaseIncome	91000	usd
CY2024Q2	bbai	Number Of Subleases NumberOfSubleases	2	sublease
CY2023Q2	bbai	Number Of Subleases NumberOfSubleases	4	sublease
	us-gaap	Operating Lease Payments OperatingLeasePayments	1003000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	691000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5942000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1200000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2357000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2275000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1695000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1688000	usd
CY2024Q2	bbai	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	9065000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18280000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7641000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	10639000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1077000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9562000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2024Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	2800000	usd
CY2024Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	2800000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	246774184	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157287522	shares
	bbai	Common Stock Voting Rights Vote For Each Share CommonStockVotingRightsVoteForEachShare	1	vote
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5127673	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y10D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2209000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	87324	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.35
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	800858	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	60915	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.43
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4178576	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M23D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	372000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1430565	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y3M18D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	150000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5749000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3994000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10906000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7799000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-11737000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16895000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-136884000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43109000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246303139	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	246303139	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145469043	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145469043	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	216754082	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	216754082	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142027938	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142027938	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11620538	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19316029	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10073689	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20188407	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39783000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38459000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72904000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80613000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	171000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	980000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	230000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	98000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	73000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	675000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	73000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1557000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	117000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	176000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	127000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1655000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	127000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1655000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39783000	usd
CY2024Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72904000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38459000	usd
CY2023Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80613000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1041000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4822000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3496000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	879000	usd
	bbai	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	900000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	82200000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.93
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-036497-index-headers.html	Edgar Link	pending
0001628280-24-036497-index.html	Edgar Link	pending
0001628280-24-036497.txt	Edgar Link	pending
0001628280-24-036497-xbrl.zip	Edgar Link	pending
bbai-20240630.htm	Edgar Link	pending
bbai-20240630.xsd	Edgar Link	pending
exhibit311-ceocertificatio.htm	Edgar Link	pending
exhibit312-cfocertificatio.htm	Edgar Link	pending
exhibit321-906ceo6302024.htm	Edgar Link	pending
exhibit322-906cfo6302024.htm	Edgar Link	pending
bbai-20240630_cal.xml	Edgar Link	unprocessable
bbai-20240630_def.xml	Edgar Link	unprocessable
bbai-20240630_lab.xml	Edgar Link	unprocessable
bbai-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bbai-20240630_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBAI
BigBear.ai Holdings Inc Stock $bbai

2024 Q3 Form 10-Q Financial Statement

#000162828024036497 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI BigBear.ai Holdings Inc Stock $bbai

2024 Q3 Form 10-Q Financial Statement

#000162828024036497 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI
BigBear.ai Holdings Inc Stock $bbai